GSK Extends Product Portfolio In Middle East, North Africa
Published: 02-Jul-2009
Business comprises a portfolio of 13 branded pharmaceuticals
GlaxoSmithKline (GSK) has acquired the branded generics business of Bristol Myers Squibb in Lebanon, Jordan, Syria, Libya and Yemen for $23.2 million. The business comprises a portfolio of 13 branded pharmaceuticals.
The company said that this is a strategy to accelerate growth in emerging markets and to provide medicines to patients in the Middle East and North Africa.
The acquisition builds upon GSK’s previous purchases of mature branded products in 2008 from Bristol Myers Squibb in Pakistan and Egypt, which included a manufacturing plant in Giza, Greater Cairo. Bristol Myers Squibb will continue to supply the products acquired until 2011, when it is anticipated that manufacture will transfer to GSK’s Giza plant.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
Enabling Drug Delivery Deal Making
Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...
Automating Training Control Processes to Comply with FDA Requirements
Well-managed training programs minimize the risk of non-compliance and improve product qua ...
TNO Pharma Services: From Discovery to the Clinic
Our kinetics & metabolism experts can help you select and further develop your candidate d ...
